7 May 2025 - The vaccine must not be used in people 65 years and above while review is underway. ...
28 February 2025 - 46 human medicinal products with new active substances authorised. ...
16 January 2025 - In 2024, EMA recommended 114 medicines for marketing authorisation. ...
20 December 2024 - At its September 2024 meeting, the PBAC considered a report presenting a utilisation analysis of PBS ...
9 December 2024 - The Outcome Statements are now available for the Oral Contraceptives Stakeholder Meeting held on 10 October 2024 ...
3 December 2024 - The Minister for Health and Aged Care, the Hon Mark Butler MP has announced the Implementation Advisory ...
15 November 2024 - The outcome statement from the October 2024 DUSC meeting is now available. ...
10 September 2024 - A Government review of Australia’s systems for accessing medicine has said it could slash waiting times ...
10 September 2024 - The reports of the HTA Review and the Enhanced Consumer Engagement Process have been published. ...
10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...
6 July 2024 - The Orphan Drug Act was enacted in the United States in 1983 in response to growing awareness ...
2 July 2024 - The FDA’s rare paediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations ...
5 June 2024 - This year’s analysis will include the top ten commercial formularies by covered lives, and include drugs ...
30 May 2024 - EMA’s annual report 2023 published today details the Agency’s contributions to public and animal health in the ...
7 May 2024 - In this cohort study of cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did ...